Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

Palisade Bio (PALI) EPS (Weighted Average and Diluted) (2016 - 2025)

Historic EPS (Weighted Average and Diluted) for Palisade Bio (PALI) over the last 10 years, with Q3 2025 value amounting to -$0.38.

  • Palisade Bio's EPS (Weighted Average and Diluted) rose 8362.07% to -$0.38 in Q3 2025 from the same period last year, while for Sep 2025 it was -$2.12, marking a year-over-year increase of 8485.71%. This contributed to the annual value of -$10.5 for FY2024, which is 6113.06% up from last year.
  • Palisade Bio's EPS (Weighted Average and Diluted) amounted to -$0.38 in Q3 2025, which was up 8362.07% from -$0.58 recorded in Q2 2025.
  • In the past 5 years, Palisade Bio's EPS (Weighted Average and Diluted) ranged from a high of $1.87 in Q4 2022 and a low of -$12.96 during Q1 2022
  • Moreover, its 5-year median value for EPS (Weighted Average and Diluted) was -$3.77 (2023), whereas its average is -$3.88.
  • Its EPS (Weighted Average and Diluted) has fluctuated over the past 5 years, first soared by 16363.64% in 2021, then plummeted by 107619.05% in 2022.
  • Quarter analysis of 5 years shows Palisade Bio's EPS (Weighted Average and Diluted) stood at $0.42 in 2021, then soared by 345.24% to $1.87 in 2022, then crashed by 301.6% to -$3.77 in 2023, then surged by 36.61% to -$2.39 in 2024, then surged by 84.1% to -$0.38 in 2025.
  • Its last three reported values are -$0.38 in Q3 2025, -$0.58 for Q2 2025, and -$0.47 during Q1 2025.